Eton Pharmaceuticals Inc. (ETON) Reports Q1 EPS of $0.19

Eton Pharmaceuticals Inc. (NASDAQ: ETON) reported Q1 EPS of $0.19, versus ($0.50) reported last year. Revenue for the quarter came in at $11.9 million, versus $99 thousand reported last year.

For earnings history and earnings-related data on Eton Pharmaceuticals Inc. (ETON) click here.

You May Also Be Interested In

• Academy Sports and Outdoor (ASO) Tops Q2 EPS by 22c, Offers Guidance
• ON Semiconductor (ON) Reiterated at Neutral by Cantor Fitzgerald Amid Cyclical Recovery
• J.Jill (JILL) Tops Q2 EPS by 67c, Beats on Revenue; Offers Guidance